Cyndi A Speelman, MD | |
8244 E Us Highway 36 Ste 1310, Avon, IN 46123-9627 | |
(317) 838-3955 | |
(317) 718-2955 |
Full Name | Cyndi A Speelman |
---|---|
Gender | Female |
Speciality | Family Practice |
Experience | 27 Years |
Location | 8244 E Us Highway 36 Ste 1310, Avon, Indiana |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1871597542 | NPI | - | NPPES |
200169360 | Medicaid | IN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 01048967 (Indiana) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Hendricks Regional Health | Danville, IN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Hendricks County Hospital | 4880505528 | 274 |
News Archive
Medical device company Vertos Medical, Inc., developer of the mild® procedure for lumbar spinal stenosis (LSS), today announced it has completed a $15.5 million Series D financing. New investor, ONSET Ventures, led the round with additional participation from existing Vertos investors CHL Medical Partners, Foundation Medical Partners, Aweida Venture Partners and DFJ Mercury.
Magnetic resonance imaging is prognostic for newborn infants with hypoxic-ischemic encephalopathy regardless of treatment with hypothermia, research shows.
Biodel Inc. announced today that it has selected two new formulations of recombinant human insulin for clinical testing and is accelerating clinical development plans of these mealtime insulin drug candidates. The new formulations, BIOD-105 and BIOD-107, are designed to result in more rapid insulin action compared to currently marketed meal time insulin analogs while maintaining an injection site tolerability profile comparable to currently marketed insulins.
Reliv International, Inc., a nutrition and direct selling company, today reported consolidated net sales of $18.7 million for the third quarter of 2010, compared to net sales of $20.9 million in the third quarter of last year.
› Verified 4 days ago
Entity Name | Hendricks County Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1063411551 PECOS PAC ID: 4880505528 Enrollment ID: O20040811000309 |
News Archive
Medical device company Vertos Medical, Inc., developer of the mild® procedure for lumbar spinal stenosis (LSS), today announced it has completed a $15.5 million Series D financing. New investor, ONSET Ventures, led the round with additional participation from existing Vertos investors CHL Medical Partners, Foundation Medical Partners, Aweida Venture Partners and DFJ Mercury.
Magnetic resonance imaging is prognostic for newborn infants with hypoxic-ischemic encephalopathy regardless of treatment with hypothermia, research shows.
Biodel Inc. announced today that it has selected two new formulations of recombinant human insulin for clinical testing and is accelerating clinical development plans of these mealtime insulin drug candidates. The new formulations, BIOD-105 and BIOD-107, are designed to result in more rapid insulin action compared to currently marketed meal time insulin analogs while maintaining an injection site tolerability profile comparable to currently marketed insulins.
Reliv International, Inc., a nutrition and direct selling company, today reported consolidated net sales of $18.7 million for the third quarter of 2010, compared to net sales of $20.9 million in the third quarter of last year.
› Verified 4 days ago
Entity Name | Union Associated Physicians Clinic Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1891028379 PECOS PAC ID: 3375687437 Enrollment ID: O20100213000002 |
News Archive
Medical device company Vertos Medical, Inc., developer of the mild® procedure for lumbar spinal stenosis (LSS), today announced it has completed a $15.5 million Series D financing. New investor, ONSET Ventures, led the round with additional participation from existing Vertos investors CHL Medical Partners, Foundation Medical Partners, Aweida Venture Partners and DFJ Mercury.
Magnetic resonance imaging is prognostic for newborn infants with hypoxic-ischemic encephalopathy regardless of treatment with hypothermia, research shows.
Biodel Inc. announced today that it has selected two new formulations of recombinant human insulin for clinical testing and is accelerating clinical development plans of these mealtime insulin drug candidates. The new formulations, BIOD-105 and BIOD-107, are designed to result in more rapid insulin action compared to currently marketed meal time insulin analogs while maintaining an injection site tolerability profile comparable to currently marketed insulins.
Reliv International, Inc., a nutrition and direct selling company, today reported consolidated net sales of $18.7 million for the third quarter of 2010, compared to net sales of $20.9 million in the third quarter of last year.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Cyndi A Speelman, MD 1100 Southfield Dr, Suite 1370, Plainfield, IN 46168-4498 Ph: (317) 837-5571 | Cyndi A Speelman, MD 8244 E Us Highway 36 Ste 1310, Avon, IN 46123-9627 Ph: (317) 838-3955 |
News Archive
Medical device company Vertos Medical, Inc., developer of the mild® procedure for lumbar spinal stenosis (LSS), today announced it has completed a $15.5 million Series D financing. New investor, ONSET Ventures, led the round with additional participation from existing Vertos investors CHL Medical Partners, Foundation Medical Partners, Aweida Venture Partners and DFJ Mercury.
Magnetic resonance imaging is prognostic for newborn infants with hypoxic-ischemic encephalopathy regardless of treatment with hypothermia, research shows.
Biodel Inc. announced today that it has selected two new formulations of recombinant human insulin for clinical testing and is accelerating clinical development plans of these mealtime insulin drug candidates. The new formulations, BIOD-105 and BIOD-107, are designed to result in more rapid insulin action compared to currently marketed meal time insulin analogs while maintaining an injection site tolerability profile comparable to currently marketed insulins.
Reliv International, Inc., a nutrition and direct selling company, today reported consolidated net sales of $18.7 million for the third quarter of 2010, compared to net sales of $20.9 million in the third quarter of last year.
› Verified 4 days ago
Ronald Stegemoller, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 5250 E Us Highway 36, Suite 610, Avon, IN 46123 Phone: 317-745-5403 Fax: 317-718-2180 | |
Dr. Wendy Allison Mason, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8244 E Us Highway 36, Ste. 1100, Avon, IN 46123 Phone: 317-272-7500 Fax: 317-272-7515 | |
Mr. Eric D Clark, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 8244 E Us Highway 36, Suite 1100, Avon, IN 46123 Phone: 317-272-7500 Fax: 317-272-7515 | |
Amelia S Bruner, RN Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7990 E Us Highway 36, Avon, IN 46123 Phone: 619-599-6637 | |
Charles H Tripple, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 8244 E Us Highway 36, Suite 1100, Avon, IN 46123 Phone: 317-272-7500 Fax: 317-272-7515 | |
Mark Benson, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 8607 E Us Highway 36 Ste 100, Avon, IN 46123 Phone: 317-745-5403 | |
Dr. Daniel Kevin Storey, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8607 E Us Highway 36 Ste 100, Avon, IN 46123 Phone: 317-745-5403 |